New study could give boost to digital mammo

Digital mammography is widely regarded as a powerful new tool in the detection of breast cancer. Yet, thus far the technology is not broadly utilized with the FDA estimating that fewer than 10 percent of breast screening facilities use the new systems.
   
A hoped-for boost to the technology could be on the way in the form of a report from the American College of Radiology Imaging Network (ACRIN) comparing the effectiveness of digital mammography versus conventional x-ray. The results will be released on Sept. 16.

The cost of digital mammography systems might seem prohibitive, but digital mammography systems are likely to provide a big return on investment (ROI) in the long run for facilities that install them due to their speed and overall precision, as well as ease in integrating with other applications.

Also, as analog x-ray mammography systems currently in use eventually need to be replaced, the hope is that organizations will chose to replace them with digital systems.

The Millennium Research Group (MRG) has recently predicted that the U.S. digital breast imaging market is poised to jump from a current $100 million to $480 million by 2009.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.